Internal Medicine, Gastroenterology · Staten Island, NY
NPI
1083685994
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
360 Edison St
Staten Island, NY, 10306
Phone (718) 351-6377
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
1,222 services
Medicare patients, 2024
629
Average age 72
Drug cost, 2024
$428K
2,271 prescriptions
Company payments, 2025
$830
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence Mancino was code 99214 (office e&m - established), 489 times for 404 patients. In total Lawrence Mancino billed 1,222 services in 19 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 489 | 404 | $99.70 | $49K |
| 43239 Upper GI Endoscopy | Office | 195 | 188 | $333.40 | $65K |
| 45380 Lower GI Endoscopy - Other | Office | 187 | 187 | $375.31 | $70K |
| 99213 Office E&M - Established | Office | 136 | 128 | $81.06 | $11K |
| 45385 Colonoscopy - Lesion Removal | Office | 62 | 62 | $417.43 | $26K |
| 99204 Office E&M - New | Office | 60 | 60 | $106.60 | $6,396 |
| 45381 Lower GI Endoscopy - Other | Office | 15 | 15 | $95.60 | $1,434 |
| 45380 Lower GI Endoscopy - Other | Facility | 15 | 15 | $144.39 | $2,166 |
By year: 2022 $267K for 1,564 services; 2023 $253K for 1,275 services; 2024 $245K for 1,222 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence Mancino prescribed most often to Medicare patients was Pantoprazole Sodium, with 696 prescriptions and refills. In total Lawrence Mancino wrote 2,271 Medicare prescriptions that cost $428K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 696 | 1,132 | 221 | $5,081 |
| Famotidine Generic | 687 | 1,138 | 210 | $5,522 |
| Omeprazole Generic | 173 | 340 | 54 | $1,833 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 76 | 76 | 76 | $5,386 |
| Dicyclomine Hcl Generic | 60 | 61 | 29 | $425 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 48 | 48 | 48 | $3,084 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 48 | 48 | 48 | $8,248 |
| Mesalamine Generic | 41 | 63 | Under 11 | $11K |
| Linzess Linaclotide | 38 | 40 | Under 11 | $21K |
| Sucralfate Generic | 37 | 65 | 11 | $3,206 |
| Metronidazole Generic | 35 | 35 | 28 | $525 |
| Ciprofloxacin Hcl Generic | 31 | 31 | 25 | $160 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 30 | 30 | 30 | $307 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 20 | $327 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 16 | 16 | 15 | $2,533 |
Brand drugs: 217 claims; generic drugs: 2,054 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence Mancino $830 ($830 in general payments such as food, travel and fees) from 12 companies. The largest payer was Madrigal Pharmaceuticals with $196.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 19 | $196 |
| Aimmune Therapeutics, Inc. | 4 | $129 |
| Pfizer Inc. PFE | 5 | $92.31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $91.9 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $67.1 |
| Genzyme Corporation SNY | 3 | $63.48 |
| Abbvie Inc. ABBV | 2 | $42.92 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $39.98 |
| Exact Sciences Corporation EXAS | 2 | $38.16 |
| Evoke Pharma, Inc. EVOK | 1 | $24.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.